Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Cefaclor in Acute Bacterial Exacerbation of Chronic Bronchitis
NCT00257140Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 1931
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levofloxacin in chronic bronchitis (CB), sponsored by Johnson & Johnson. Started Jun 1931; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00257140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257140.